We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · June 17, 2021

Andexanet Alfa and Prothrombin Complex Concentrate in Factor Xa Inhibitor-Related Major Bleeding

Research and practice in thrombosis and haemostasis

 

Additional Info

Research and practice in thrombosis and haemostasis
A Meta-Analysis of Andexanet Alfa and Prothrombin Complex Concentrate in the Treatment of Factor Xa Inhibitor-Related Major Bleeding
Res Pract Thromb Haemost 2021 May 24;5(4)e12518, T Jaspers, K Shudofsky, MV Huisman, K Meijer, N Khorsand

Further Reading